Published online before print June 26, 2008, doi: 10.1161/STROKEAHA.108.516575
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:2929.)
© 2008 American Heart Association, Inc.
Original Contributions |
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
From Departments of Neurology (R.R.D., S.S., A.S.B., M.K.H., R.A., C.S.K., P.A.W.), Biostatistics (A.S.B., J.J.H.), Preventive Medicine (P.A.W.), Medicine (E.J.B.), and Mathematics (R.B.D.), Boston University, Boston, Mass; Department of Radiology (J.J.P.), Tufts University, Boston, Mass; The Framingham Heart Study and National Heart Lung and Blood Institute (S.S., A.S.B., M.K.H., R.A., C.S.K., E.J.B., C.J.O., R.B.D., P.A.W.), Framingham, Mass; and Department of Neurology (C.D., M.Y.), University of California-Davis, Davis Calif.
Correspondence to Sudha Seshadri, MD, DM, Department of Neurology, Boston University School of Medicine, 715 Albany Street, B 605, Boston, MA 02118. E-mail suseshad{at}bu.edu
Background and Purpose— Previous estimates of the prevalence of silent cerebral infarction (SCI) on MRI in community-based samples have varied between 5.8% and 17.7% depending on age, ethnicity, presence of comorbidities, and imaging techniques. We document the prevalence and risk factors associated with SCI at midlife in the community-based Framingham sample.
Methods— Our study sample comprised 2040 Framingham Offspring (53% female; mean age, 62±9 years) who attended the sixth examination (1996–1998), underwent volumetric brain MRI (1999–2005,) and were free of clinical stroke at MRI. We examined the age- and sex-specific prevalences and the clinical correlates of SCI using multivariable logistic regression models.
Results— At least 1 SCI was present in 10.7% of participants; 84% had a single lesion. SCI was largely located in the basal ganglia (52%), other subcortical (35%) areas, and cortical areas (11%). Prevalent SCI was associated with the Framingham Stroke Risk Profile score (OR, 1.27; 95% CI, 1.10–1.46); stage I hypertension was determined by JNC-7 criteria (OR,1.56; CI,1.15–2.11), an elevated plasma homocysteine in the highest quartile (OR, 2.23; CI, 1.42–3.51), atrial fibrillation (OR, 2.16; CI, 1.07–4.40), carotid stenosis >25% (OR, 1.62; 1.13–2.34), and increased carotid intimal-medial thickness above the lowest quintile (OR, 1.65; CI, 1.22–2.24).
Conclusion— The prevalence and distribution of SCI in the Framingham Offspring are comparable to previous estimates. Risk factors previously associated with clinical stroke were also found to be associated with midlife SCI. Our results support current guidelines emphasizing early detection and treatment of stroke risk factors.
Key Words: carotid intimal medial thickness • carotid stenosis • carotid ultrasound • cerebral infarct • epidemiology • homocysteinemia • imaging • magnetic resonance • prevention
Related Article:
Stroke 2008 39: 2919-2920.
This article has been cited by other articles:
 |
|
 |
|
  A. S. Buchman, D. Tanne, P. A. Boyle, R. C. Shah, S. E. Leurgans, and D. A. Bennett Kidney function is associated with the rate of cognitive decline in the elderly Neurology, September 22, 2009; 73(12): 920 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pikula, R. H. Boger, A. S. Beiser, R. Maas, C. DeCarli, E. Schwedhelm, J. J. Himali, F. Schulze, R. Au, M. Kelly-Hayes, et al. Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study Stroke, September 1, 2009; 40(9): 2959 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Dhamoon, Y. P. Moon, M. C. Paik, B. Boden-Albala, T. Rundek, R. L. Sacco, and M. S.V. Elkind Long-Term Functional Recovery After First Ischemic Stroke: The Northern Manhattan Study Stroke, August 1, 2009; 40(8): 2805 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, W. Wen, K. J. Anstey, and P. S. Sachdev Prevalence, incidence, and risk factors of lacunar infarcts in a community sample Neurology, July 28, 2009; 73(4): 266 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Armario and A. de la Sierra Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents? Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 197 - 204. [Abstract] [PDF]
|
|
|
|
|
|
J. Putaala, M. Kurkinen, V. Tarvos, O. Salonen, M. Kaste, and T. Tatlisumak Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke Neurology, May 26, 2009; 72(21): 1823 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Thompson and A. M. Hakim Living Beyond Our Physiological Means: Small Vessel Disease of the Brain Is an Expression of a Systemic Failure in Arteriolar Function: A Unifying Hypothesis Stroke, May 1, 2009; 40(5): e322 - e330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Meier Stroke and migraine: a cardiologist's headache Heart, April 1, 2009; 95(7): 595 - 602. [Full Text] [PDF]
|
|
|
|
 |
|
 WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF]
|
|
|
|
|
|
K. Rockwood and G. Gubitz Silent Cerebral Infarction: Are We Listening? Stroke, November 1, 2008; 39(11): 2919 - 2920. [Full Text] [PDF]
|
|